Menu Search
Equities

OraSure Technologies Inc

OSUR:NSQ

OraSure Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.85
  • Today's Change0.04 / 1.05%
  • Shares traded883.85k
  • 1 Year change-46.38%
  • Beta0.0435
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year OraSure Technologies Inc grew revenues 4.64% from 387.48m to 405.47m while net income improved from a loss of 17.13m to a gain of 53.66m.
Gross margin42.26%
Net profit margin5.59%
Operating margin-5.32%
Return on assets2.72%
Return on equity2.74%
Return on investment2.94%
More ▼

Cash flow in USDView more

In 2023, OraSure Technologies Inc increased its cash reserves by 245.80%, or 206.43m. The company earned 141.58m from its operations for a Cash Flow Margin of 34.92%. In addition the company generated 66.15m cash from investing, though they paid out 3.02m more in financing than they received.
Cash flow per share0.329
Price/Cash flow per share11.61
Book value per share5.71
Tangible book value per share5.22
More ▼

Balance sheet in USDView more

OraSure Technologies Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio12.60
Quick ratio11.20
Total debt/total equity0.0004
Total debt/total capital0.0004
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 405.24%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)75.98
EPS (TTM) vs
TTM 1 year ago		-77.53
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.